Physostigma venenosum
Species
KNApSAcK Entry
| Organism name | Physostigma venenosum |
|---|---|
| Genus | Physostigma |
| Family | Fabaceae |
| Kingdom | Plantae |
NCBI taxonomy
Entry
| Linked NCBI taxonomy name | Physostigma venenosum |
|---|---|
| Linked NCBI taxonomy ID | 271807 |
| Linked level | species |
Family
| Family in NCBI taxonomy | Fabaceae |
|---|---|
| ID | 3803 |
Kingdom (Superkingdom)
| Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
|---|---|
| ID | 33090 |
Plant class
| Plant class | rosids |
|---|---|
| ID | 71275 |
Natural Activity
List (18)
| Species | Activity |
|---|---|
| Physostigma venenosum Balf. | Anticholinesterase |
| Physostigma venenosum Balf. | Anticuraroid |
| Physostigma venenosum Balf. | Antidote |
| Physostigma venenosum Balf. | Antidote, curare |
| Physostigma venenosum Balf. | Cardiodepressant |
| Physostigma venenosum Balf. | Insecticide |
| Physostigma venenosum Balf. | Mitotic |
| Physostigma venenosum Balf. | Myotic |
| Physostigma venenosum Balf. | Negative Chronotropic |
| Physostigma venenosum Balf. | Paralytic |
| Physostigma venenosum Balf. | Parasiticide |
| Physostigma venenosum Balf. | Parasympathomimetic |
| Physostigma venenosum Balf. | Pediculicide |
| Physostigma venenosum Balf. | Peristaltic |
| Physostigma venenosum Balf. | Poison |
| Physostigma venenosum Balf. | Rodenticide |
| Physostigma venenosum Balf. | Sedative |
| Physostigma venenosum Balf. | Spasmogenic |
Metabolite list (5)
| KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
|---|---|---|---|---|---|---|---|---|
C00003674
|
Stigmasterol
/ beta-Stigmasterol |
CHEMBL66943
CHEMBL186373 CHEMBL400247 CHEMBL1568947 |
D013265
|
5 / 0 / 0 | 1 / 0 | No. 53 | No. 11 |
|
|
C00001757
|
Physostigmine
|
CHEMBL94
CHEMBL11773 CHEMBL306319 CHEMBL76640 CHEMBL382351 CHEMBL1243269 |
D010830
|
109 / 58 / 52 | 5 / 83 | No. 2568 | No. 4 |
|
|
C00001726
|
Eseridine
|
CHEMBL123248
|
C060406
|
2 / 1 / 0 | No. 2568 | No. 4 |
|
|
|
C00001758
|
Physovenine
|
CHEMBL362444
CHEMBL205940 CHEMBL205231 |
C092643
|
2 / 1 / 0 | No. 2568 | No. 4 |
|
|
|
C00001725
|
Eseramine
|
CHEMBL77799
|
No. 2568 | No. 4 |
|
Human Protein / Gene in interactions
114 ChEMBL Protein in interactions
| accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
|---|---|---|---|---|
| P06276 | Cholinesterase | Hydrolase | C00001726 C00001757 C00001758 | 0 / 0 |
| P22303 | Acetylcholinesterase | Hydrolase | C00001726 C00001757 C00001758 | 1 / 0 |
| P09884 | DNA polymerase alpha catalytic subunit | Transferase | C00003674 | 0 / 0 |
| P21728 | D(1A) dopamine receptor | Dopamine receptor | C00001757 | 0 / 0 |
| P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00001757 | 0 / 3 |
| Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00001757 | 2 / 2 |
| P08246 | Neutrophil elastase | S1A | C00001757 | 2 / 1 |
| P33765 | Adenosine receptor A3 | Adenosine receptor | C00001757 | 0 / 0 |
| Q16539 | Mitogen-activated protein kinase 14 | p38 | C00001757 | 0 / 0 |
| P06746 | DNA polymerase beta | Enzyme | C00003674 | 0 / 0 |
| P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00001757 | 0 / 0 |
| P29466 | Caspase-1 | C14 | C00001757 | 0 / 0 |
| P17252 | Protein kinase C alpha type | Alpha | C00001757 | 0 / 0 |
| P27361 | Mitogen-activated protein kinase 3 | Erk | C00001757 | 0 / 0 |
| P14780 | Matrix metalloproteinase-9 | M10A | C00001757 | 2 / 2 |
| P02545 | Prelamin-A/C | Unclassified protein | C00001757 | 11 / 10 |
| P00918 | Carbonic anhydrase 2 | Lyase | C00001757 | 1 / 2 |
| P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00001757 | 0 / 1 |
| P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00001757 | 1 / 1 |
| P25021 | Histamine H2 receptor | Histamine receptor | C00001757 | 0 / 0 |
| P35367 | Histamine H1 receptor | Histamine receptor | C00001757 | 0 / 0 |
| Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00001757 | 1 / 0 |
| P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00001757 | 0 / 0 |
| P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00001757 | 0 / 0 |
| P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00001757 | 0 / 0 |
| P34969 | 5-hydroxytryptamine receptor 7 | Serotonin receptor | C00003674 | 0 / 0 |
| P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00001757 | 0 / 0 |
| P06241 | Tyrosine-protein kinase Fyn | Src | C00001757 | 0 / 0 |
| Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00001757 | 0 / 0 |
| P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00001757 | 0 / 1 |
| P54132 | Bloom syndrome protein | Enzyme | C00001757 | 1 / 2 |
| P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00001757 | 1 / 8 |
| P14416 | D(2) dopamine receptor | Dopamine receptor | C00001757 | 2 / 0 |
| P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00001757 | 0 / 0 |
| P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00001757 | 0 / 0 |
| P41145 | Kappa-type opioid receptor | Opioid receptor | C00001757 | 0 / 0 |
| Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00001757 | 0 / 0 |
| P29274 | Adenosine receptor A2a | Adenosine receptor | C00001757 | 0 / 0 |
| P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00001757 | 0 / 0 |
| P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00001757 | 1 / 1 |
| P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00001757 | 0 / 0 |
| P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00001757 | 1 / 0 |
| P00352 | Retinal dehydrogenase 1 | Enzyme | C00001757 | 0 / 0 |
| P38571 | Lysosomal acid lipase/cholesteryl ester hydrolase | Enzyme | C00001757 | 1 / 1 |
| P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00001757 | 0 / 0 |
| Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | C00001757 | 0 / 0 |
| Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00001757 | 0 / 0 |
| O75496 | Geminin | Unclassified protein | C00001757 | 0 / 0 |
| P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00001757 | 0 / 0 |
| P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00001757 | 0 / 0 |
| P21917 | D(4) dopamine receptor | Dopamine receptor | C00001757 | 0 / 0 |
| P30988 | Calcitonin receptor | Calcitonin receptor | C00001757 | 0 / 0 |
| P35462 | D(3) dopamine receptor | Dopamine receptor | C00001757 | 1 / 0 |
| P41143 | Delta-type opioid receptor | Opioid receptor | C00001757 | 0 / 0 |
| Q92731 | Estrogen receptor beta | NR3A2 | C00001757 | 0 / 1 |
| P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00001757 | 0 / 0 |
| P25101 | Endothelin-1 receptor | Endothelin receptor | C00001757 | 0 / 0 |
| P30411 | B2 bradykinin receptor | Bradykinin receptor | C00001757 | 0 / 0 |
| P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00001757 | 1 / 0 |
| P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00001757 | 0 / 0 |
| P08311 | Cathepsin G | S1A | C00001757 | 0 / 0 |
| Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00001757 | 1 / 0 |
| O00519 | Fatty-acid amide hydrolase 1 | Enzyme | C00001757 | 0 / 0 |
| P03956 | Interstitial collagenase | M10A | C00001757 | 0 / 1 |
| P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00001757 | 0 / 0 |
| O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00001757 | 0 / 0 |
| P04150 | Glucocorticoid receptor | NR3C1 | C00001757 | 0 / 1 |
| P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00001757 | 2 / 0 |
| P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00001757 | 0 / 0 |
| P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00001757 | 0 / 0 |
| P31645 | Sodium-dependent serotonin transporter | Serotonin | C00001757 | 2 / 0 |
| P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00001757 | 5 / 9 |
| P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00001757 | 1 / 0 |
| P21452 | Substance-K receptor | Neurokinin receptor | C00001757 | 0 / 0 |
| P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00001757 | 1 / 0 |
| P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00001757 | 0 / 0 |
| P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00001757 | 3 / 0 |
| P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00001757 | 0 / 0 |
| P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00001757 | 1 / 0 |
| P28482 | Mitogen-activated protein kinase 1 | Erk | C00001757 | 0 / 0 |
| P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00001757 | 2 / 1 |
| P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00001757 | 0 / 0 |
| O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00001757 | 0 / 0 |
| P03372 | Estrogen receptor | NR3A1 | C00001757 | 1 / 1 |
| P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00001757 | 1 / 0 |
| P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00001757 | 2 / 0 |
| Q16637 | Survival motor neuron protein | Unclassified protein | C00001757 | 4 / 1 |
| P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00001757 | 0 / 0 |
| P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00001757 | 0 / 0 |
| P35372 | Mu-type opioid receptor | Opioid receptor | C00001757 | 0 / 0 |
| P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00001757 | 0 / 0 |
| P25103 | Substance-P receptor | Neurokinin receptor | C00001757 | 0 / 0 |
| P25105 | Platelet-activating factor receptor | PAF receptor | C00001757 | 0 / 0 |
| P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00001757 | 0 / 0 |
| P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00001757 | 1 / 1 |
| P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00001757 | 0 / 1 |
| P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00001757 | 0 / 0 |
| Q99549 | M-phase phosphoprotein 8 | Unclassified protein | C00001757 | 0 / 0 |
| Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00001757 | 0 / 0 |
| P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00001757 | 1 / 1 |
| P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00001757 | 0 / 0 |
| P30542 | Adenosine receptor A1 | Adenosine receptor | C00001757 | 0 / 0 |
| P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00001757 | 0 / 0 |
| P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00001757 | 1 / 1 |
| P06239 | Tyrosine-protein kinase Lck | Src | C00001757 | 0 / 1 |
| P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00001757 | 0 / 0 |
| B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00001757 | 0 / 0 |
| Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00001757 | 0 / 0 |
| O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | C00001757 | 1 / 0 |
| O00255 | Menin | Unclassified protein | C00001757 | 2 / 5 |
| Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00001757 | 1 / 2 |
| P11388 | DNA topoisomerase 2-alpha | Isomerase | C00003674 | 0 / 0 |
| Q02880 | DNA topoisomerase 2-beta | Isomerase | C00003674 | 0 / 0 |
| O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | C00001757 | 0 / 0 |
6 Gene in CTD interactions
| gene | gene name | gene description | KNApSAcK metabolite in interactions |
|---|---|---|---|
| 13 | AADAC, CES5A1, DAC | arylacetamide deacetylase (EC:3.1.1.3) |
C00001757
|
| 43 | ACHE, ACEE, ARACHE, N-ACHE, YT | acetylcholinesterase (EC:3.1.1.7) |
C00001757
|
| 8824 | CES2, CE-2, CES2A1, PCE-2, iCE | carboxylesterase 2 (EC:3.1.1.1 3.1.1.84 3.1.1.56) |
C00001757
|
| 1137 | CHRNA4, BFNC, EBN, EBN1, NACHR, NACHRA4, NACRA4 | cholinergic receptor, nicotinic, alpha 4 (neuronal) |
C00001757
|
| 1141 | CHRNB2, EFNL3, nAChRB2 | cholinergic receptor, nicotinic, beta 2 (neuronal) |
C00001757
|
| 10599 | SLCO1B1, HBLRR, LST-1, LST1, OATP-C, OATP1B1, OATP2, OATPC, SLC21A6 | solute carrier organic anion transporter family, member 1B1 |
C00003674
|
Related Diseases
Diseases related to proteins in ChEMBL interactions
OMIM (58)
| OMIM | preferred title | UniProt |
|---|---|---|
| #100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
| #103780 | Alcohol dependence |
P08172
P14416 P31645 |
| #614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
| #210900 | Bloom syndrome; blm |
P54132
|
| #602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
| #300615 | Brunner syndrome |
P21397
|
| #115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
| #212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
| #605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
| #162800 | Cyclic neutropenia |
P08246
|
| #612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
| #609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
| #608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
| #181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
| #615363 | Estrogen resistance; estrr |
P03372
|
| #613659 | Gastric cancer |
P04626
|
| #137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
| #231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
| #137800 | Glioma susceptibility 1; glm1 |
O75874
P04626 |
| #605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
| #610140 | Heart-hand syndrome, slovenian type |
P02545
|
| #609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
| #176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
| #145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
| #603932 | Intervertebral disc disease; idd |
P14780
|
| #151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
| #613688 | Long qt syndrome 2; lqt2 |
Q12809
|
| #211980 | Lung cancer |
P00533
P04626 |
| #278000 | Lysosomal acid lipase deficiency |
P38571
|
| #608516 | Major depressive disorder; mdd |
P08172
|
| #248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
| %300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
| #613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
| #131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
| #126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
| #613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
| #159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
| #159900 | Myoclonic dystonia |
P14416
|
| #202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
| #601665 | Obesity |
P32245
|
| #164230 | Obsessive-compulsive disorder; ocd |
P31645
|
| #604715 | Orthostatic intolerance |
P23975
|
| #259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
| #167000 | Ovarian cancer |
P04626
|
| #613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
| #607276 | Resting heart rate, variation in |
P08588
|
| #275210 | Restrictive dermopathy, lethal |
P02545
|
| #604906 | Schizophrenia 9; sczd9 |
P49798
|
| #181500 | Schizophrenia; sczd |
P49798
|
| #608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
| #609620 | Short qt syndrome 1; sqt1 |
Q12809
|
| #253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
| #253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
| #253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
| #271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
| #190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
| #610379 | West nile virus, susceptibility to |
P51681
|
| #112100 | Yt blood group antigen |
P22303
|
KEGG DISEASE (52)
| KEGG | name | UniProt |
|---|---|---|
| H00033 | Adrenal carcinoma |
O00255
(related)
|
| H00034 | Carcinoid |
O00255
(related)
|
| H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
| H00246 | Primary hyperparathyroidism |
O00255
(related)
|
| H01102 | Pituitary adenomas |
O00255
(related)
|
| H00016 | Oral cancer |
P00533
(related)
P00533 (marker) |
| H00017 | Esophageal cancer |
P00533
(related)
P35354 (related) |
| H00018 | Gastric cancer |
P00533
(related)
P04626 (related) |
| H00022 | Bladder cancer |
P00533
(related)
P04626 (related) |
| H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) |
| H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
| H00042 | Glioma |
P00533
(related)
P00533 (marker) |
| H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) |
| H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
| H00436 | Osteopetrosis |
P00918
(related)
|
| H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
| H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
| H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
| H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
| H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
| H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
| H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
| H00663 | Restrictive dermopathy |
P02545
(related)
|
| H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
| H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
| H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) Q92731 (marker) |
| H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
| H00019 | Pancreatic cancer |
P04626
(related)
|
| H00027 | Ovarian cancer |
P04626
(related)
|
| H00031 | Breast cancer |
P04626
(related)
P04626 (marker) |
| H00046 | Cholangiocarcinoma |
P04626
(related)
P35354 (related) |
| H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
| H00079 | Asthma |
P07550
(related)
|
| H00100 | Neutropenic disorders |
P08246
(related)
|
| H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
| H00036 | Osteosarcoma |
P08684
(marker)
|
| H01205 | Coumarin resistance |
P11712
(related)
|
| H00025 | Penile cancer |
P14780
(related)
P35354 (related) |
| H00479 | Metaphyseal dysplasias |
P14780
(related)
|
| H00548 | Brunner syndrome |
P21397
(related)
|
| H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
| H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
| H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
| H00148 | Lysosomal acid lipase deficiency |
P38571
(related)
|
| H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
|
| H00094 | DNA repair defects |
P54132
(related)
|
| H00296 | Defects in RecQ helicases |
P54132
(related)
|
| H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q03164
(related)
Q03164 (marker) |
| H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
| H00720 | Long QT syndrome |
Q12809
(related)
|
| H00725 | Short QT syndrome |
Q12809
(related)
|
| H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
|
Diseases related to CTD interactions
83 disease in interactions with metabolites
| MESH or OMIM | name |
KNApSAcK
metabolite |
|---|---|---|
| D000544 | Alzheimer Disease |
C00001757
|
| D000647 | Amnesia |
C00001757
|
| D001049 | Apnea |
C00001757
|
| D001145 | Arrhythmias, Cardiac |
C00001757
|
| D001264 | Athetosis |
C00001757
|
| D001281 | Atrial Fibrillation |
C00001757
|
| D054537 | Atrioventricular Block |
C00001757
|
| D001919 | Bradycardia |
C00001757
|
| D002545 | Brain Ischemia |
C00001757
|
| D002375 | Catalepsy |
C00001757
|
| D002385 | Cataplexy |
C00001757
|
| D002493 | Central Nervous System Diseases |
C00001757
|
| D023341 | Chills |
C00001757
|
| D002819 | Chorea |
C00001757
|
| D019970 | Cocaine-Related Disorders |
C00001757
|
| D003072 | Cognition Disorders |
C00001757
|
| D003128 | COMA |
C00001757
|
| D003221 | Confusion |
C00001757
|
| D003244 | Consciousness Disorders |
C00001757
|
| D055191 | Delayed Emergence from Anesthesia |
C00001757
|
| D003693 | Delirium |
C00001757
|
| D003866 | Depressive Disorder |
C00001757
|
| D006970 | Disorders of Excessive Somnolence |
C00001757
|
| D062787 | Drug Overdose |
C00001757
|
| D064420 | Drug-Related Side Effects and Adverse Reactions |
C00001757
|
| D004409 | Dyskinesia, Drug-Induced |
C00001757
|
| D004421 | Dystonia |
C00001757
|
| D020821 | Dystonic Disorders |
C00001757
|
| D004831 | Epilepsies, Myoclonic |
C00001757
|
| D005207 | Fasciculation |
C00001757
|
| D005334 | Fever |
C00001757
|
| D015812 | Glaucoma, Angle-Closure |
C00001757
|
| D006212 | Hallucinations |
C00001757
|
| D006323 | Heart Arrest |
C00001757
|
| D006816 | Huntington Disease |
C00001757
|
| D006948 | Hyperkinesis |
C00001757
|
| D006973 | Hypertension |
C00001757
|
| D007008 | Hypokalemia |
C00001757
|
| D007022 | Hypotension |
C00001757
|
| D007024 | Hypotension, Orthostatic |
C00001757
|
| D007035 | Hypothermia |
C00001757
|
| D007247 | Infertility, Female |
C00001757
|
| D007859 | Learning Disorders |
C00001757
|
| D053609 | Lethargy |
C00001757
|
| D008325 | Mammary Neoplasms, Experimental |
C00001757
|
| D008569 | Memory Disorders |
C00001757
|
| D001523 | Mental Disorders |
C00001757
|
| D015877 | Miosis |
C00001757
|
| D019964 | Mood Disorders |
C00001757
|
| D009069 | Movement Disorders |
C00001757
|
| D015878 | Mydriasis |
C00001757
|
| D009207 | Myoclonus |
C00001757
|
| D009325 | Nausea |
C00001757
|
| D009461 | Neurologic Manifestations |
C00001757
|
| D009759 | Nystagmus, Pathologic |
C00001757
|
| D009886 | Ophthalmoplegia |
C00001757
|
| D010146 | Pain |
C00001757
|
| D010554 | Personality Disorders |
C00001757
|
| D010939 | Plant Poisoning |
C00001757
|
| D011041 | Poisoning |
C00001757
|
| D011183 | Postoperative Complications |
C00001757
|
| D020250 | Postoperative Nausea and Vomiting |
C00001757
|
| D011595 | Psychomotor Agitation |
C00001757
|
| D011596 | Psychomotor Disorders |
C00001757
|
| D011605 | Psychoses, Substance-Induced |
C00001757
|
| D012131 | Respiratory Insufficiency |
C00001757
|
| D012640 | Seizures |
C00001757
|
| D012798 | Sialorrhea |
C00001757
|
| D020181 | Sleep Apnea, Obstructive |
C00001757
|
| D013064 | Speech Disorders |
C00001757
|
| D013132 | Spinocerebellar Degenerations |
C00001757
|
| D013226 | Status Epilepticus |
C00001757
|
| D053608 | Stupor |
C00001757
|
| D013375 | Substance Withdrawal Syndrome |
C00001757
|
| D013610 | Tachycardia |
C00001757
|
| D013616 | Tachycardia, Sinus |
C00001757
|
| D017180 | Tachycardia, Ventricular |
C00001757
|
| D016171 | Torsades de Pointes |
C00001757
|
| D014202 | Tremor |
C00001757
|
| D014474 | Unconsciousness |
C00001757
|
| D014693 | Ventricular Fibrillation |
C00001757
|
| D014839 | Vomiting |
C00001757
|
| D014987 | Xerostomia |
C00001757
|